Wednesday, 11 February

#BioManuDACH2026 | BioPharma & Academic

By IMAPAC Pte Ltd

The premier biopharma gathering driving bioprocess innovation and market growth across the DACH region

Date and time

Location

Switzerland

Switzerland Switzerland Switzerland Switzerland

Agenda

Scaling Next-Gen Biologics in DACH

Industry Roundtables: The Future of Biomanufacturing

Upstream Process Intensification

Advances in Downstream Processing

Continuous Manufacturing

Single-Use Technologies vs Stainless Steel

Automation & AI in Biologics Manufacturing

Scaling Platforms & Facilities for Future Modalities

Good to know

Highlights

1 day, 10 hours
In person

Refund Policy

No Refunds

About this event

Science & Tech • Science

With the global biologics market expected to surpass $600 billion by 2030, driven by the rise of next-generation modalities and rapid advances in manufacturing technologies, Biologics Manufacturing DACH 2026 offers a premier platform for industry leaders to explore innovation, share expertise, and build strategic partnerships.

As the DACH region strengthens its role as a hub for cutting-edge biologics production, this conference brings together manufacturers, technology providers, and developers to tackle the industry’s most pressing challenges in a focused, highly networked setting.

Organised by

IMAPAC Pte Ltd

Followers

--

Events

--

Hosting

--